EQUITY RESEARCH MEMO
Antibody Solutions
Generated 5/10/2026
Executive Summary
Conviction (model self-assessment)65/100
Antibody Solutions is a privately held CRO headquartered in Sunnyvale, California, founded in 1994. The company specializes in custom antibody discovery and development, offering end-to-end services from antigen design through antibody manufacturing. Its fee-for-service model targets biopharmaceutical clients advancing diagnostics and therapeutics, emphasizing 'fit-for-purpose' antibodies. With over 25 years of domain expertise, Antibody Solutions has established a reputation for high-quality, tailored antibody solutions in a competitive CRO market.
Upcoming Catalysts (preview)
- Q4 2026Potential partnership with a large pharmaceutical company for therapeutic antibody development40% success
- Q3 2026Launch of a next-generation antibody discovery platform (e.g., phage display or single B cell technology)50% success
- Q2 2027Expansion of manufacturing capacity to meet growing demand for preclinical antibody supply70% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)